Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Walgreen Company : Walgreen April Same-Store Sales Fall Bigger-Than-Expected 6.4%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 02:39pm CEST

Walgreen Co.'s (WAG) April same-store sales fell a bigger-than-expected 6.4%--marking the fourth straight month of declines--as the drug-store chain's loss of Express Scripts Holding Co.'s (ESRX) members continued to hamper results.

Analysts polled by Thomson Reuters expected April same-store sales to fall 5.1%.

A conflict between Walgreen and Express Scripts over new contract terms erupted publicly last June, and Walgreen said it wouldn't be part of the pharmacy-benefits manager's network when their deal expired in 2011. The benefit manager's clients now have to go elsewhere to fill prescriptions.

Total sales fell 3.7% to $5.78 billion last month.

April same-pharmacy sales decreased 8.9% and missed the analysts' projected 8.6% decline.

Total pharmacy sales fell 6.3%. Prescriptions filled at same-stores declined 7.8% in April, reflecting the loss of Express Scripts members, a lower incidence of flu and more generic drug introductions. Prescriptions processed by Express Scripts comprised 12.6% of Walgreen's prescriptions a year earlier.

In the front of the store, same-store sales slipped fell 2.2% last month, compared with the analysts' flat front-end same-store sales forecast.

Total front-end sales slipped 0.5%. Customer traffic at same-stores fell 3% and average basket size increased 0.8%.

Walgreen reported in March its fiscal second-quarter earnings fell 7.7% as its exit from Express Scripts's network and a mild cold and flu season offset a 0.8% pop in total sales.

Shares closed Wednesday at $34.15 and were inactive premarket. The stock has gained 3.3% since the beginning of the year.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
09/28 WALGREENS : and United Nations Foundation Launch 2016 Get a Shot. Give a Shot.® ..
09/28 WALGREENS BOOTS ALLIANCE : Strs Ohio Purchases 6,836 Shares of Walgreens Boots A..
09/28 WALGREENS BOOTS ALLIANCE : Collaborates with National Association of Specialty P..
09/26 WALGREENS BOOTS ALLIANCE : Charles R. Walgreen III, Former Walgreen Co. Chairman..
09/24 WALGREENS BOOTS ALLIANCE : PT Lowered to $102.00 at Cowen and Company (WBA)
09/22 WALGREENS BOOTS ALLIANCE : Foyston Gordon Payne Inc buys $18,986,378 stake in Wa..
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/22 RITE AID : 2Q profit drops on higher costs, revenue rises
09/20 STOCKS IN THE SPOTLIGHT : Dollar General Corporation (DG), Walgreens Boots Allia..
09/19 WALGREENS : Launches Skin Care Platform Providing Convenient Access to Dermatolo..
More news
Sector news : Drug Retailers - NEC
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/09DJWALGREENS BOOTS ALLIANCE : To Divest Additional Stores -- WSJ
09/08DJWALGREENS BOOTS ALLIANCE : to Divest Additional Stores for Pending Rite Aid Tie-..
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2016 117 879 M
EBIT 2016 7 096 M
Net income 2016 4 030 M
Debt 2016 10 410 M
Yield 2016 1,78%
P/E ratio 2016 21,42
P/E ratio 2017 17,45
EV / Sales 2016 0,83x
EV / Sales 2017 0,80x
Capitalization 87 635 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 92,3 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%87 321
CVS HEALTH CORP-7.37%95 874
WALGREENS BOOTS ALLIAN..-4.91%87 321
EXPRESS SCRIPTS HOLDIN..-19.01%44 512
MCKESSON CORPORATION-15.65%37 281
CARDINAL HEALTH INC-12.47%24 598
More Results